Registration dossiers autorizados april 2010

R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
RE TAI L MA RKE T (WHOL ESAL ER S AND PH ARM AC IES)
MOLECULE
REFERENCE PRODUCT

Acyclovir
Dexketoprofen
Solution for injection/Concentrate for solution for Doxazosin

Fluoxetine
Gabapentin
Glimepiride

Glucosamine Sulphate

Ibuprofen-lysine

Memantine
Mirtazapine
Pantoprazole
Quetiapine
Venlafaxine
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT

Acyclovir
Lyophilised powder for solution for infusion
Amoxicillin + clavulanic acid

Cefepime

Cefonicid
Powder and solvent for solution for injection
Cefotaxime
Powder and solvent for solution for injection Powder and solvent for solution for injection/infusion
Ceftazidime
Powder and solvent for solution for injection

Ceftriaxone
Powder and solvent for solution for injection

Cis-atracurium

2 mg/mL (5 mL and 10 mL), 5 mg/mL (30 mL)
Cefuroxime (Sodium)
Powder and solvent for solution for injection Powder for solution for injection/infusion Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT

Clindamycin
150 mg/ml (300 mg/2 ml, 600 mg/4 ml, 900 mg/6 ml)
Dexketoprofen

Solution for injection/Concentrate for solution for
Fluconazole

Flumazenil

Granisetron

Iron sucrose
Solution for injection/concentrate solution for infusion 20 mg/ml
Ketorolac Trometamol

Levofloxacin

Meropenem


Midazolam
1 mg/ml (5 mg/5 ml), 5 mg/ml (15 mg/3 ml and 50 mg/10 ml)
Pamidronate
Lyophilised powder for solution for infusion Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. April 2010 R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT
Pantoprazole
Lyophilised powder for solution for injection/infusion
Paracetamol


Phenytoin

Piperacillin/Tazobactam
Lyophilised powder and solvent for solution for injection
Lyophilised powder for solution for injection
Remifentanil

Lyophilised powder for solution for injection/infusion Stilamin® (Serono, IT, NL, CH.) Somatostatin
Lyophilised powder and solvent for solution for infusion Modustatine® (Clin Midy, FR.)
Teicoplanina

Lyophilised powder and solvent for solution for injection
Vancomycin
Lyophilised powder for solution for injection
Zidovudine
Capsules

Zoledronic

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.

Source: http://combino-pharm.net/upload/productos/PRODUCTOS%20INTERNACIONAL.pdf

Layout

STANDARD NETWORK MEMBERS SAVE TIME AND MONEY ON PRESCRIPTIONS What is FastStart? FastStartSM by Caremark helps you access valuable discounts through prescriptions by mail. Order many maintenance medications—those you refill monthly for conditions like diabetes, high blood pressure, or asthma—and save up to 33% off a three-month supply. Please refer to your Plan Benefit Summary in

Relais et intégration des signaux intracellulaires

Intracellular signal relay and integrationThe development, plasticity and regenerative capabilities of the nervous system involves the proliferation of precursor cells,their differentiation, migration and the formation of their complex interconnexions. These various processes are under thecontrol of extracellular cues inducing intracellular signaling pathways whose relay and integration i

Copyright © 2008-2018 All About Drugs